Patrick Lally has over 15 years of healthcare investing experience and joined Petrichor as a Partner at launch. He is responsible for the Fund’s investing activities and serves on the boards of Aurion Biotech, CorneaGen, ITM, Persivia, and Vero.
Tadd S. Wessel is the founder and Managing Partner of Petrichor. Mr. Wessel was formerly a Managing Director at OrbiMed Advisors, where he led the build out of the healthcare special situations and structured finance business.
Petrichor launched in 2018 to support healthcare managers and businesses. Its platform spans company formation through late-stage and commercial growth opportunities, using a long-term and strategic approach.
Petrichor Healthcare Capital Management’s Website Privacy Policy covers personal data and information that the firm may collect through the Site. It applies to individuals and may be changed at any time without notice.
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management: Specializing in healthcare investment and financial services in New York.